Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug Targeting
Wenxin Wang, Wei Li, Dan Zhang, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 132-132
Open Access | Times Cited: 11

Showing 11 citing articles:

The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis, Nikolaοs Tentolouris, Natalia G. Vallianou, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 388-388
Open Access | Times Cited: 4
Genetic association of lipid-lowering drug target genes with pancreatic cancer: a Mendelian randomization study
Bai‐Horng Su, Zhiyao Fan, Jianguo Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The role of lipids and lipids lowering drugs in human papillomavirus (HPV) and HPV-associated cancers
Ehsan Shabani, Aida Hasanzadi, Omer Qutaiba B. Allela, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Adverse Events Associated with Inclisiran: A Real-world pharmacovigilance study of FDA adverse event reporting system (FAERS)
Bing Li, Yan Chen, Y. Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Reduction in Liver Cancer Risk by Quercetin via Modulation of Urate Levels: Insights from Drug-Target Mendelian Randomization
Zhengwen Li, Yue Wang, Kai Yang, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 449-449
Open Access
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Jinshuai Li, Zixian Yang, Tao Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The Causal Relationship between PCSK9 Inhibitors and Osteoporosis Based on Drug-Targeted Mendelian Combined Mediation Analysis
Naidan Zhang, Chaixia Ji, Emily Liu, et al.
Calcified Tissue International (2024) Vol. 115, Iss. 1, pp. 53-62
Open Access | Times Cited: 1
Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancers
Haozhao Liang, Chunling Tang, Yue Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Lipids, lipid-lowering drug target genes and pancreatic cancer: a Mendelian randomization study
Yuxuan Zhan, Kai Zhang, Yiqun Fan, et al.
Research Square (Research Square) (2024)
Closed Access
NR0B2 Is a Key Factor for Gastric Diseases: A GEO Database Analysis Combined with Drug-Target Mendelian Randomization
Zhengwen Li, Lijia Xu, Dongliang Huang, et al.
Genes (2024) Vol. 15, Iss. 9, pp. 1210-1210
Open Access
Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancers
Haozhao Liang, Chunling Tang, Yue Sun, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top